Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Why Index Level Rises Indicators explains the reasons behind rising index levels and how to respond with prudent actions.
23,291 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
The toy story 5 trailer sparked laughs over Woody's balding head, but it also reveals a smart path to managing entert...
A blockchain analysis firm flags a pattern of Russia-linked crypto platforms routing large transfers to evade sanctio...
Standard Chartered projects stablecoins could generate up to $1 trillion of new US Treasury demand by 2028, signaling...
The Dutch labor market is short nearly 400,000 workers across logistics, tech, healthcare, and construction. For EU c...
Investors can buy stakes in the first Atari Hotel Phoenix via a Regulation A+ offering, marking a bold move by the ic...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
The Trade Desk prepares to report quarterly results as investors grapple with a steep stock drop, focusing on revenue...
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...
Retail investors are increasingly offered access to private-market products as Wall Street courts Main Street. But ex...
DeCaro Auctions appoints Mario Vargas as CEO, signaling a bold push into private-client advisory services and cross-b...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...